Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

512

Participants

Timeline

Start Date

May 23, 2016

Primary Completion Date

June 4, 2019

Study Completion Date

June 4, 2019

Conditions
Diabetes Mellitus, Type 2
Interventions
BEHAVIORAL

REACH

The intervention consists of daily text messaging tailored to user's individual barriers to medication adherence, text messages assessing user's adherence with feedback on progress, plus text messaging targeting other self-care behaviors.

BEHAVIORAL

Helpline and A1c results

Participants complete study assessments, receive text messages advising how to access study A1c results, receive quarterly newsletters on healthy living with diabetes, and have access to a helpline for study- or diabetes medication-related questions.

BEHAVIORAL

REACH + FAMS

The intervention consists of REACH individually-focused text messaging, plus family-focused phone coaching session, goal-focused text messaging, and the option to invite a family member/support person to receive text messaging.

Trial Locations (1)

37203

Federally Qualified Health Centers and Vanderbilt Primary Care Clinics, Nashville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Vanderbilt University Medical Center

OTHER

NCT02409329 - Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter